Efficacy of Copanlisib Monotherapy in Patients With Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis From the CHRONOS-1 Trial

被引：0
|
作者：
Martin, Peter [1 ]
机构：
[1] Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, Med, New York, NY 10065 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2018年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [31] Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open-label, registration directed Phase II study
    Fowler, Nathan H.
    Samaniego, Felipe
    Jurczak, Wojciech
    Lech-Maranda, Ewa
    Ghosh, Nilanjan
    Anz, Bertrand
    Patten, Piers
    Reeves, James A.
    Leslie, Lori A.
    Smolewski, Piotr
    Chavez, Julio C.
    Ghia, Paolo
    Tarella, Corrado
    Burke, John M.
    Sharman, Jeff
    Kolibaba, Kathryn
    O'Connor, Owen A.
    Cheah, Chan Y.
    Miskin, Hari P.
    Sportelli, Peter
    Weiss, Michael S.
    Zinzani, Pier Luigi
    CANCER RESEARCH, 2019, 79 (13)
  • [32] Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open label, registration directed phase II study.
    Fowler, Nathan Hale
    Samaniego, Felipe
    Jurczak, Wojciech
    Lech-Maranda, Ewa
    Ghosh, Nilanjan
    Patten, Piers
    Reeves, James Andrew
    Leslie, Lori Ann
    Chavez, Julio C.
    Ghia, Paolo
    Tarella, Corrado
    Burke, John M.
    Sharman, Jeff Porter
    Kolibaba, Kathryn
    O'Connor, Owen A.
    Cheah, Chan
    Miskin, Hari P.
    Sportelli, Peter
    Weiss, Michael S.
    Zinzani, Pier Luigi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Copanlisib monotherapy activity in relapsed or refractory indolent B-cell lymphoma: Combined analysis from phase I and II studies
    Zinzani, P. L.
    Santoro, A.
    Mollica, L.
    Follows, G. A.
    Bouabdallah, K.
    Morschhauser, F.
    Patnaik, A.
    Huang, L.
    Hiemeyer, F.
    Benson, A.
    Genvresse, I.
    Garcia-Vargas, J. E.
    Childs, B. H.
    Dreyling, M. H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma
    Satoshi Yamasaki
    Dai Chihara
    Isao Yoshida
    Kyuhei Kohda
    Masashi Sawa
    Hiroatsu Ago
    Kazuto Togitani
    Yuju Ohno
    Junji Tanaka
    Takahiro Fukuda
    Yoshiko Atsuta
    Junji Suzumiya
    Ritsuro Suzuki
    Annals of Hematology, 2019, 98 : 1521 - 1523
  • [35] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma
    Yamasaki, Satoshi
    Chihara, Dai
    Yoshida, Isao
    Kohda, Kyuhei
    Sawa, Masashi
    Ago, Hiroatsu
    Togitani, Kazuto
    Ohno, Yuju
    Tanaka, Junji
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Suzumiya, Junji
    Suzuki, Ritsuro
    ANNALS OF HEMATOLOGY, 2019, 98 (06) : 1521 - 1523
  • [36] Impact of Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Marginal Zone Lymphoma
    Yamasaki, Satoshi
    Chihara, Dai
    Yoshida, Isao
    Kohda, Kyuhei
    Sawa, Masashi
    Ago, Hiroatsu
    Togitani, Kazuto
    Ohno, Yuju
    Tanaka, Junji
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Suzumiya, Junji
    Suzuki, Ritsuro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [37] Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1
    Goto, Hideki
    Kumode, Takahiro
    Mishima, Yuko
    Kataoka, Keisuke
    Ogawa, Yoshiaki
    Kanemura, Nobuhiro
    Shimada, Kazuyuki
    Uchida, Toshiki
    Kuroe, Yukano
    Kawasaki, Atsuko
    Sato, Jotaro
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025, 30 (02) : 389 - 396
  • [38] HIGH-DOSE CLARITHROMYCIN IS A FEASIBLE AND ACTIVE MONOTHERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY EXTRANODAL MARGINAL ZONE LYMPHOMA [EMZL]: RESULTS FROM THE "HD-K" PHASE II TRIAL
    Ferreri, A. J.
    Sassone, M.
    Kiesewetter, B.
    Govi, S.
    Scarfo, L.
    Donadoni, G.
    Raderer, M.
    HAEMATOLOGICA, 2014, 99 : 142 - 142
  • [39] Ibrutinib Therapy in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Analysis By Prior Rituximab Treatment and Baseline Mutations
    Chen, Robert
    de Vos, Sven
    Thieblemont, Catherine
    Martin, Peter
    Flowers, Christopher
    Morschhauser, Franck
    Collins, Graham
    Ma, Shuo
    Coleman, Morton
    Peles, Shachar
    Smith, Stephen D.
    Barrientos, Jacqueline C.
    Smith, Alina
    Munneke, Brian
    Wu, Shiquan
    Cheung, Leo
    Kwei, Kevin
    Samakoglu, Selda
    Arango-Hisijara, Israel
    Dimery, Isaiah
    Noy, Ariela
    BLOOD, 2017, 130
  • [40] Safety and efficacy of clarithromycin monotherapy in patients (pts) with extranodal marginal zone lymphoma (EMZL)
    Cecchetti, C.
    Kiesewetter, B.
    Sassone, M.
    Calimeri, T.
    Scarfo, L.
    Raderer, M.
    Ferreri, A.
    ANNALS OF ONCOLOGY, 2016, 27
12345